ArticleInternational journal of clinical pharmacy2025

Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting System.

Kaidi Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.